Sarepta Therapeutics (SRPT) Other Non-Current Assets (2010 - 2026)

Sarepta Therapeutics has reported Other Non-Current Assets for 17 years, with the latest figure at $152.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets rose 875.4% year-over-year to $152.0 million; the trailing twelve-month figure through Mar 2026 stood at $152.0 million (up 875.4% YoY), and the FY2025 full-year result was $5.2 million, down 93.51% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $152.0 million, up from $5.2 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $293.1 million in Q3 2022, with the low at $2.1 million in Q2 2022.
• Average Other Non-Current Assets over 5 years is $63.0 million, with a median of $15.6 million recorded in 2024.
• Year-over-year, Other Non-Current Assets surged 8344.94% in 2022 and slumped 99.24% in 2023.
• Tracing SRPT's Other Non-Current Assets over 5 years: stood at $163.0 million in 2022, then slipped by 16.08% to $136.8 million in 2023, then slumped by 41.57% to $79.9 million in 2024, then plunged by 93.51% to $5.2 million in 2025, then surged by 2827.88% to $152.0 million in 2026.
• The last three Other Non-Current Assets figures came in at $152.0 million (Q1 2026), $5.2 million (Q4 2025), and $4.2 million (Q3 2025), per Business Quant data.

Peer Comparison